Current Approaches to Ulcerative Colitis Management: A Comprehensive Overview of Methodologies and Treatments.

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Ulcerative colitis (UC) is a chronic idiopathic inflammatory condition of the colon, part of inflammatory bowel disease.
• Pathophysiology involves genetic, environmental, and inflammatory factors, with onset typically in individuals aged 30-40.
• Disease progression starts rectally and moves proximally, marked by recurrent mucosal inflammation.

Purpose of the Study:

• To provide a comprehensive understanding of ulcerative colitis.
• To highlight current and evolving treatment options for UC.
• To review available dosage forms and their impact on patient compliance.

Main Methods:

• Literature review of ulcerative colitis pathophysiology and management.
• Analysis of current therapeutic strategies, including biologics and small molecules.
• Examination of various available dosage forms for UC treatment.

Main Results:

• Treatment severity guides management strategies for ulcerative colitis.
• Emerging therapies include anti-tumor necrosis factor-alpha monoclonal antibodies and Janus Kinase inhibitors.
• Diverse dosage forms (tablets, capsules, suppositories) exist to achieve clinical and endoscopic remission.

Conclusions:

• Ulcerative colitis management is evolving with new therapeutic agents and drug delivery systems.
• Optimizing dosage forms is critical for enhancing patient compliance and treatment efficacy.
• Continued research promises further improvements in managing this chronic inflammatory condition.